Restore Islet Function , Embrace a Healthier Future

Doublle Bio harnesses cutting-edge UC-MSC technology to offer Type 2 Diabetes patients a next-generation regenerative medicine solution – repairing islet B-cells from the root.

Common Challenges
for Diabetic Patients

lype 2 Diabetes has become a “silent epidemic” threatening modern health.
Millions of patients face unrelenting daily struggles-and conventional treatments often only manage symptoms without addressing the root cause.

“Testing, injecting, medicating-day after day…Is this really all there is?’

🧬

Differentiate into islet β-cells to restore insulin secretion function

🛡️

Modulate immune response and reduce islet inflammation

Improve insulin resistance and enhance tissue sensitivity to insulin

🩸

Promote angiogenesis and improve the islet microenvironment

Doublle Bio
5 Core Competencies

From pioneering research to GMP-grade manufacturing and Phase III clinical experience — we have built every layer of the value chain to deliver safe, effective, and transformative stem cell therapies.